FDA Inspection
New York Blood Center, Inc.New York Blood Center, Inc. – FDA Inspection, Dec 19, 2022
Record Details
This FDA Inspection record concerns New York Blood Center, Inc., with an inspection on December 19, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- New York Blood Center, Inc.
- Inspection Date
- December 19, 2022
- Product Type
- Biologics
View Company Profile
ID · c76cf2c4-354e-4d81-8fe6-6cb1edadedaf
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1194222
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of New York Blood Center, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 25, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 7, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 10, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 19, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center, Inc.
- FDA Inspection 1094266 - 2019-06-24
- FDA Inspection 1009901 - 2017-04-25
- FDA Inspection 903225 - 2014-11-07
- FDA Inspection 831324 - 2013-05-10
- FDA Inspection 751007 - 2011-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.